NP031112
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NP031112, covering 2012-01-05 to 2012-01-05. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of Two Different Oral Doses of NP031112 Versus Placebo in the Treatment of Patients With Mild-to-Moderate Progressive Supranuclear Palsy [NA]